The objective of RENACER is to carry out basic and clinical studies that help to advance the development of therapies for these metastases With prior consent from the patients, surgeons will collec...
Read moreChildhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Although pediatric cancer death rates have declined over the past four decades due to improved tu...
Read moreAptadel Therapeutics is a preclinical company co-founded by IDIBELL focused on developing a new platform for targeted therapy against cancer. This platform consists of nanoparticles loaded with therap...
Read moreXavier Trepat and international experts remind us in a piece published in the Journal Nature by science writer Amber Dance, the crucial role of physics in order to understand biological entities such ...
Read moreCiQUS will be involved in REAP, a newly European project to reveal drug tolerant persister cells by contrast enhanced multimodal optical imaging. BioNanoTools, the group led by Beatriz Pelaz, will dev...
Read moreLa leucemia linfoblástica aguda de tipo T (LLA-T) es un cáncer sanguíneo que afecta principalmente a niños, aunque también de forma menos frecuente a adultos. En estos últimos, a pesar de que la...
Read moreLa inmunoterapia oncológica es un tipo de tratamiento que estimula las defensas naturales del cuerpo con el fin de combatir el cáncer. A pesar de que se trata de una de las estrategias más prometed...
Read moreEn un trabajo de revisión coordinado por Javier Oliver Pozo, jefe de grupo del CIBERONC en el Instituto de Parasitología y Biomedicina López Neyra-CSIC los investigadores plantean la interacció...
Read moreA complete integrated freeze-drying system designed for high value anticancer products consisting of a reduced foot-print freeze dryer with an innovative loading/unloading system, integrating a steam-...
Read moreA single tumour, or even a single cancer cell, can present multiple genetic alterations at the same time: point mutations, lose or gain of specific genetic fragments, among others. Understanding how t...
Read moreEl grupo del CIBERONC, dirigido por Amancio Carnero, investigador del CSIC en el Instituto de Biomedicina de Sevilla (IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Su...
Read moreLa Universitat Politècnica de València (UPV), a través del grupo CVBLab-I3B, lidera CLARIFY, un proyecto europeo centrado en la patología digital cuyo objetivo es facilitar el diagnóstico d...
Read more